The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response: A translational sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
 
Bonnita Werner
Travel, Accommodations, Expenses - Oxford Nanopore Technologies
 
Katrin Marie Sjoquist
Honoraria - BMS; Merck; MSD; Novotech (Inst); Novotech (Inst); SERVIER
Research Funding - Bayer (Inst)
Other Relationship - Novotech
 
David Espinoza
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
Garry Chang
No Relationships to Disclose
 
Michelle M. Cummins
No Relationships to Disclose
 
Linda R. Mileshkin
Research Funding - BeiGene (Inst)
 
Sumitra Ananda
No Relationships to Disclose
 
Catherine M. Shannon
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; GlaxoSmithKline; Lilly; Merck sharp and Dohme; Roche
Speakers' Bureau - Amgen; AstraZeneca; Gilead Sciences; GlaxoSmithKline; merk sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis
 
Michael Friedlander
Honoraria - AstraZeneca; GlaxoSmithKline; MSD; Novartis
Consulting or Advisory Role - Abbvie; AstraZeneca; Eisai; GlaxoSmithKline; Incyclix Bio; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); BeiGene (Inst); Novartis (Inst)
 
Kristina Warton
Stock and Other Ownership Interests - Epigenomics; Exact Sciences; Guardant Health
 
Caroline Ford
Research Funding - Boehringer Ingelheim